Artgen Biotech (ABIO) Stock Forecast
Gripped
AI forecast: ABIO
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
ABIO: score, valuation and dividends
AI-Stock Invest describes the company by published rules: its Smart Score against peers, valuation against the sector, dividend history checked across sources, and red flags. The same for every reader — information, not a forecast and not advice.
Open in AI-Stock Invest → ABIO dividend historyPremium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
Artgen Biotech is a biotechnology company that develops and introduces into healthcare practice biomedical drugs, vaccines, gene therapies, regenerative medicine and cell therapy products, as well as medical devices for tissue engineering and genetic research.
